Navigating the SPAC Route to Nasdaq
Mount Sinai Health System-backed Sema4 was set to debut on the Nasdaq, raising $500M to “step on the gas” and accelerate the growth of its healthcare intelligence platform. Going public in a SPAC transaction meant kicking PR into high gear during a compressed time frame relative to a traditional IPO. Making the PR challenge even more daunting, the debut business combination announcement – the most compelling media moment – had already been announced months earlier.
While details of the deal were being finalized, the PR team went to work to create market visibility for a debut missing the sizzle of a traditional IPO. Bospar developed a media relations strategy positioning Sema4’s listing as a capital markets event worth of coverage, leveraging its debut as marking a transformative step towards delivering on its long-term mission to combine genomic and clinical data in a precision medicine model to improve the standard of care for patients.
Sema4’s went public at $3B valuation with a feature story in The Wall Street Journal, articles in high-profile trade publications Fierce Healthcare, Bio-IT World and Becker’s Hospital Review and coverage in The Hartford Courant and Hartford Business Journal.